Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer

por Wu, Yutuan, Jennings, Nicholas B., Sun, Yunjie, Dasari, Santosh K., Bayraktar, Emine, Corvigno, Sara, Stur, Elaine, Glassman, Deanna, Mangala, Lingegowda S., Lankenau Ahumada, Adrian, Westin, Shannon N., Sood, Anil K., Hu, Wei
Publicado 2022

Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer

por Zhao, Li, Corvigno, Sara, Ma, Shaolin, Celestino, Joseph, Fleming, Nicole D., Hajek, Richard A., Lankenau Ahumada, Adrian, Jennings, Nicholas B., Thompson, Erika J., Tang, Hongli, Westin, Shannon N., Jazaeri, Amir A., Zhang, Jianhua, Futreal, P. Andrew, Sood, Anil K., Lee, Sanghoon
Publicado 2022